EARN25

Biotech Stock Soars on Potential FDA Fast-Track

Call traders are finally taking an interest

Deputy Editor
Oct 4, 2022 at 1:58 PM
facebook X logo linkedin


The shares of Inhibrx Inc (NASDAQ:INBX) are soaring today, up 41.1% at $28.48 at last glance, after the company alluded to potentially accelerated U.S. Food & Drug Administration (FDA) approval of its treatment for rare lung disease. Jefferies noted that this is the best-case scenario for the treatment, called INBRX-101, which is being developed to treat patients with emphysema due to alpha-1 antitrypsin (AAT) deficiency.

Wall Street has been pessimistic towards the equity prior to today, and it appears that sentiment carried over into the options pits as well. Puts have greatly outweighed calls, as the latter has been virtually nonexistent. Today, however, 1,576 calls have crossed the tape, which is 175 times the intraday average, alongside 1,466 puts -- six times what's typically seen at this point. The October 30 call is the most popular, with new positions being bought to open there. 

On the charts, today's pop has INBX trading at its highest level since January, though the stock is still down 36.3% since the start of the year. The equity is also breaking above pressure at the 200-day moving average, which kept a lid on the shares' August rally. 

INBX Oct4

It's also worth noting that short interest makes up 13.3% of the stock's available float. It would take roughly seven days to buy back these bearish bets, at Inhibrx stock's average daily pace of trading. 

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!